Clinical Trials
3 trialsNCT00087685 2025-05-01
RAD001 in Recurrent Endometrial Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00870337 2014-10-29
ENDORAD
ARCAGY/ GINECO GROUP
Phase 2 Completed
NCT00703807 2014-01-14
Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
Yale University
Phase 1 Completed